TY - JOUR
T1 - Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas
T2 - A Consensus Opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe
AU - Terwisscha van Scheltinga, Sheila
AU - Schoot, Reineke A.
AU - Routh, Jonathan C.
AU - Seitz, Guido
AU - Kao, Simon C.
AU - de Keizer, Bart
AU - Shulkin, Barry
AU - Ewijk, Roelof van
AU - McCarville, Beth
AU - Casey, Dana
AU - Allen-Rhoades, Wendy
AU - Mercolini, Federico
AU - Merks, Hans
AU - Orbach, Daniel
AU - Kapadia, Tejas
AU - Walterhouse, David O.
AU - Davila Fajardo, Raquel
AU - Hiemcke-Jiwa, Laura
AU - Franzius, Christiane
AU - De Corti, Federica
AU - Tang, Vivian
AU - Metts, Jonathan
AU - Oberoi, Saphna
AU - Vokuhl, Christian
AU - Dasgupta, Roshni
AU - Birz, Suzi
AU - Rodeberg, David
N1 - Publisher Copyright:
© 2025 Wiley Periodicals LLC.
PY - 2025/4
Y1 - 2025/4
N2 - Accurate staging of nodal involvement in pediatric sarcoma patients is important to determine correct systemic and local therapy, with the goal to reduce subsequent recurrences. However, differences in lymph node staging strategies, definitions, and treatment protocols between the Children's Oncology Group (COG), European paediatric Soft tissue sarcoma Study Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS) complicate comparisons. In this article, we aim to establish internationally recognized recommendations for lymph node assessment and treatment of children and adolescents diagnosed with rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) according to the Consensus Conference Standard Operating Procedure methodology.
AB - Accurate staging of nodal involvement in pediatric sarcoma patients is important to determine correct systemic and local therapy, with the goal to reduce subsequent recurrences. However, differences in lymph node staging strategies, definitions, and treatment protocols between the Children's Oncology Group (COG), European paediatric Soft tissue sarcoma Study Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS) complicate comparisons. In this article, we aim to establish internationally recognized recommendations for lymph node assessment and treatment of children and adolescents diagnosed with rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) according to the Consensus Conference Standard Operating Procedure methodology.
KW - including soft tissue
KW - non-rhabdoid
KW - pediatric oncology
KW - rhabdomyosarcoma
KW - sarcomas
UR - http://www.scopus.com/inward/record.url?scp=85215670590&partnerID=8YFLogxK
U2 - 10.1002/pbc.31538
DO - 10.1002/pbc.31538
M3 - Article
C2 - 39844722
AN - SCOPUS:85215670590
SN - 1545-5009
VL - 72
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 4
M1 - e31538
ER -